Rimonabant vs Taranabant
While Sanofi’s diet pill Rimonabant (Acomplia / Zimulti) remains stalled at the FDA, a potential competitor currently in phase III trials, Merck’s MK-0364, now has an official generic name: Taranabant.Taranabant is Merck’s cannabinoid-1 (CB-1) receptor inverse agonist, and from reports we periodically ...
Comments Off